ES2187063T3 - Derivados de azetidinona para el tratamiento de infecciones por hcmv. - Google Patents

Derivados de azetidinona para el tratamiento de infecciones por hcmv.

Info

Publication number
ES2187063T3
ES2187063T3 ES98947255T ES98947255T ES2187063T3 ES 2187063 T3 ES2187063 T3 ES 2187063T3 ES 98947255 T ES98947255 T ES 98947255T ES 98947255 T ES98947255 T ES 98947255T ES 2187063 T3 ES2187063 T3 ES 2187063T3
Authority
ES
Spain
Prior art keywords
alkyl
het
aryl
phenyl
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98947255T
Other languages
English (en)
Inventor
Eric Malenfant
Robert Deziel
William W Ogilvie
Jeffrey O'meara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Application granted granted Critical
Publication of ES2187063T3 publication Critical patent/ES2187063T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula 1:**(Fórmula)** en la que Y es O ó S; R1 es fenilo, 4-cloro-fenilo, bencilo, feniletilo, 2-piridinilmetilo, 3-piridinilmetilo, 4-piridinilmetilo, CH2-(S)CH(CH2CH2SO2Me)-NH-Tbg-Boc, CH2-(S)CH(CH2CHMe2)-NH-Tbg-C(O)CH2-t-Bu; R4 es H o Me; R12 es fenilo, benciloxietilo o Het; y R13 es hidrógeno, metilo, etilo, propilo o hidroximetilo, en la que Het incluye pirrolidina, tetrahidrofurano, tiazolidina, pirrol, 1H-imidazol, 1-metil-1H-imidazol, pirazol, furano, tiofeno, oxazol, isoxazol, tiazol, 2-metiltiazol, 2-aminotiazol, 2-(metilamino)-tiazol, piperidina, 1-metilpiperidina, 1-metilpiperazina, 1, 4-dioxano, morfolina, piridina, N-óxido de piridina, pirimidina, 2, 4-dihidroxipirimidina, 2, 4-dimetilpirimidina, 2, 6-dimetilpiridina, 1-metil-1H-tetrazol, 2-metil-2Htetrazol, benzotiazol, benzoxazol y tiazolo[4, 5-b]piridina; Tbg representa terc-butilglicina; y Boc representa erc-butiloxicarbonilo, con la condición de que queda excluido el 1-(N-bencilcarbamoil)-4-(feniltio)-azetidin-2-ona.
ES98947255T 1997-10-07 1998-10-06 Derivados de azetidinona para el tratamiento de infecciones por hcmv. Expired - Lifetime ES2187063T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6155097P 1997-10-07 1997-10-07

Publications (1)

Publication Number Publication Date
ES2187063T3 true ES2187063T3 (es) 2003-05-16

Family

ID=22036487

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98947255T Expired - Lifetime ES2187063T3 (es) 1997-10-07 1998-10-06 Derivados de azetidinona para el tratamiento de infecciones por hcmv.

Country Status (11)

Country Link
US (1) US6239125B1 (es)
EP (1) EP1021404B1 (es)
JP (1) JP2001519328A (es)
AT (1) ATE230725T1 (es)
AU (1) AU9425998A (es)
CA (1) CA2301548C (es)
DE (1) DE69810651T2 (es)
DK (1) DK1021404T3 (es)
ES (1) ES2187063T3 (es)
PT (1) PT1021404E (es)
WO (1) WO1999018071A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778639B1 (en) 2004-07-15 2015-09-02 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
KR101830447B1 (ko) * 2009-05-12 2018-02-20 알바니 몰레큘라 리써치, 인크. 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202126649A (zh) 2019-09-26 2021-07-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
EP0377549B1 (en) 1989-01-03 1998-12-09 Marcos Y. Kleinerman Remote measurement of physical variables with fiber optic systems
US5100880A (en) 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
WO1995025539A1 (fr) * 1994-03-23 1995-09-28 Tokyo Tanabe Company Limited Nouveau remede contre les maladies virales des voies respiratoires
WO1997025047A1 (en) * 1996-01-11 1997-07-17 Smithkline Beecham Corporation Novel cycloalkyl substituded imidazoles
AU710876B2 (en) * 1996-02-21 1999-09-30 Darwin Discovery Limited Quinolones and their therapeutic use
JPH09255547A (ja) * 1996-03-22 1997-09-30 Kao Corp 皮膚外用剤

Also Published As

Publication number Publication date
PT1021404E (pt) 2003-04-30
JP2001519328A (ja) 2001-10-23
DE69810651D1 (de) 2003-02-13
CA2301548C (en) 2005-05-17
AU9425998A (en) 1999-04-27
US6239125B1 (en) 2001-05-29
CA2301548A1 (en) 1999-04-15
ATE230725T1 (de) 2003-01-15
WO1999018071A1 (en) 1999-04-15
DE69810651T2 (de) 2003-08-21
EP1021404A1 (en) 2000-07-26
DK1021404T3 (da) 2003-03-24
EP1021404B1 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
AU572405B2 (en) Heterocyclic-substituted indole
IL87795A (en) Benzimidazolin-2-oxo- 1-carboxylic acid ester and amide derivatives, their preparation and pharmaceutical compositions containing them
SE8201854L (sv) N-substituerade amino-aminosyror
ATE208374T1 (de) Beta-laktam und cepham verbindungen und ihre herstellung
NO975901D0 (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
ZA934997B (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives
ES2187063T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
HUP0203787A2 (hu) Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO885549L (no) Fremgangsmaate for fremstilling av amid-derivater.
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
ATE231124T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
DE69132707D1 (de) N-Acyldipeptide, und pharmazeutische Präparate davon
ES2067635T3 (es) Derivados heterociclicos de beta-aminoacidos acilaminodiolicos.
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
DE59903722D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-pyrrolidinen, Zwischenprodukte und deren Verwendung
FI922268A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi
NZ331180A (en) Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants
MX9708422A (es) Esteres de carbapenemas.
DE50000905D1 (de) Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen
HUP0203921A2 (hu) Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk